PMID- 38164502 OWN - NLM STAT- MEDLINE DCOM- 20240103 LR - 20240205 IS - 2206-7418 (Electronic) IS - 2206-7418 (Linking) VI - 8 IP - 1 DP - 2024 TI - Theranostic Phthalocyanine and Naphthalocyanine Nanoparticles for Photoacoustic Imaging and Photothermal Therapy of Tumors. PG - 100-111 LID - 10.7150/ntno.88892 [doi] AB - Background: Phthalocyanine (PC) and naphthalocyanine (NC) dyes have long garnered interest as theranostic agents for optical imaging and phototherapy due to their near-infrared absorbance, photostability, imaging contrast, and proven safety in clinical trials. Yet, only a small fraction of these dyes has been evaluated as photothermal therapy (PTT) agents for cancer treatment. Methods: Nearly 40 distinct NC and PC dyes were encapsulated within polymeric PEG-PCL micelles via oil-in-water emulsions. The optimal NC/PC-loaded micelle formulations for PTT and photoacoustic (PA) imaging were identified through in vivo and in vitro studies. Results: The most promising candidate, CuNC(Octa)-loaded micelles, demonstrated a strong PA signal with a peak absorbance at ~870 nm, high photothermal efficiency, and photostability. The CuNC(Octa)-loaded micelles exhibited heat generation as good or better than gold nanorods/nanoshells and >10-fold higher photoacoustic signals. Micelle preparation was reproducible/scalable, and the CuNC(Octa)-loaded micelles are highly stable under physiological conditions. The CuNC(Octa)-loaded micelles localize within tumors via enhanced permeability and retention and are readily detectable by PA imaging. In a syngeneic murine tumor model of triple-negative breast cancer, CuNC(Octa)-loaded micelles demonstrate efficient heat generation with PTT, leading to the complete eradication of tumors. Conclusions: CuNC(Octa)-loaded micelles represent a promising theranostic agent for PA imaging and PTT. The ability to utilize conventional ultrasound in combination with PA imaging enables the simultaneous acquisition of information about tumor morphology and micelle accumulation. PTT with CuNC(Octa)-loaded micelles can lead to the complete eradication of highly invasive tumors. CI - (c) The author(s). FAU - Tian, Yiran AU - Tian Y AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Carrillo-Malani, Nicole AU - Carrillo-Malani N AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Feng, Kailin AU - Feng K AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Miller, Joann AU - Miller J AD - Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. FAU - Busch, Theresa M AU - Busch TM AD - Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. FAU - Sundaram, Karthik M AU - Sundaram KM AD - Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Cheng, Zhiliang AU - Cheng Z AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Amirshaghaghi, Ahmad AU - Amirshaghaghi A AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. FAU - Tsourkas, Andrew AU - Tsourkas A AD - Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. LA - eng GR - R01 EB028858/EB/NIBIB NIH HHS/United States GR - R01 EB029238/EB/NIBIB NIH HHS/United States PT - Journal Article DEP - 20240101 PL - Australia TA - Nanotheranostics JT - Nanotheranostics JID - 101698994 RN - V5PUF4VLGY (phthalocyanine) RN - 0 (Micelles) RN - 0 (Indoles) RN - 0 (Coloring Agents) SB - IM MH - Animals MH - Mice MH - Micelles MH - Photothermal Therapy MH - Precision Medicine MH - *Photoacoustic Techniques/methods MH - *Nanoparticles/therapeutic use MH - Indoles MH - Coloring Agents/therapeutic use MH - *Neoplasms/therapy/drug therapy PMC - PMC10750118 OTO - NOTNLM OT - naphthalocyanine OT - photoacoustic imaging OT - photothermal therapy OT - phthalocyanine OT - theranostic COIS- Competing Interests: TMB reports other support from Simphotek and personal fees from Lumeda and IBA outside the submitted work. EDAT- 2024/01/02 11:43 MHDA- 2024/01/03 09:43 PMCR- 2024/01/01 CRDT- 2024/01/02 03:46 PHST- 2023/08/10 00:00 [received] PHST- 2023/11/02 00:00 [accepted] PHST- 2024/01/03 09:43 [medline] PHST- 2024/01/02 11:43 [pubmed] PHST- 2024/01/02 03:46 [entrez] PHST- 2024/01/01 00:00 [pmc-release] AID - ntnov08p0100 [pii] AID - 10.7150/ntno.88892 [doi] PST - epublish SO - Nanotheranostics. 2024 Jan 1;8(1):100-111. doi: 10.7150/ntno.88892. eCollection 2024.